Login / Signup

Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?

Jacqueline T BrownBassel NazhaMehmet Asim Bilen
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Keyphrases
  • renal cell carcinoma
  • tyrosine kinase